# Olanzapine

NDC: 0517-0955
Generic name: Olanzapine
Labeler / Manufacturer: American Regent, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR
Marketing started: 20120627

FDA application: ANDA201741

## Active ingredients

- OLANZAPINE: 10 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0517-0955"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0517-0955
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e9ac2bd3-dbff-4b1a-952f-da3909c6e4ee